Merck has signed a licensing agreement worth up to $3.3 billion with Shanghai-based LaNova Medicines to develop, make and ...

Merck (MRK) stock will be in focus as company inks deal worth up to $3.3B to buy licensing rights to a cancer candidate ...

Merck KGaA (MRCG.DE), opens new tab on Thursday reported a gain of 11.9% in adjusted quarterly earnings, helped by ...

Merck reported third-quarter earnings growth above expectations, helped by lower spending and a positive performance in ...

In a move to safeguard its dominant position in cancer treatments, Merck agreed to license a drug from a Chinese company ...

Merck is playing defense against Summit Therapeutics with a $3.3 billion licensing deal announced Thursday for a cancer drug.

All coupon content is created by TechRadar. We may earn a commission if you buy through our links. More Info.

IOL Chemicals and Pharmaceuticals Ltd., incorporated in the year 1986, is a Small Cap company (having a market cap of Rs 2,308.89 Crore) operating in Pharmaceuticals sector. IOL Chemicals and ...

Akums Drugs & Pharmaceuticals Ltd., incorporated in the year 2004, is a company (having a market cap of Rs 9,643.53 Crore) operating in Pharmaceuticals sector. Akums Drugs & Pharmaceuticals Ltd. key ...